Decagon Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-26,300
Closed -$1.31K 59
2024
Q4
$1.31K Buy
+26,300
New +$115K ﹤0.01% 44

Other funds holding RVNC